BBNX logo

BBNX
Beta Bionics Inc.

269
Mkt Cap
$450.52M
Volume
243,162.00
52W High
$32.71
52W Low
$8.80
PE Ratio
-6.69
BBNX Fundamentals
Price
$10.44
Prev Close
$10.11
Open
$9.83
50D MA
$10.56
Beta
1.56
Avg. Volume
1.16M
EPS (Annual)
-$1.81
P/B
1.66
Rev/Employee
$237,000.00
$1,023.00
Loading...
Loading...
News
all
press releases
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by Analysts
Shares of Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold re...
MarketBeat·26d ago
News Placeholder
More News
News Placeholder
Beta Bionics (NASDAQ:BBNX) Price Target Cut to $24.00 by Analysts at Leerink Partners
Leerink Partners decreased their price target on Beta Bionics from $25.00 to $24.00 and set an "outperform" rating on the stock in a research note on Wednesday...
MarketBeat·29d ago
News Placeholder
Beta Bionics (NASDAQ:BBNX) Shares Gap Up on Strong Earnings
Beta Bionics (NASDAQ:BBNX) Shares Gap Up on Earnings Beat...
MarketBeat·29d ago
News Placeholder
Beta Bionics (NASDAQ:BBNX) Given New $20.00 Price Target at Stifel Nicolaus
Stifel Nicolaus reduced their target price on Beta Bionics from $22.00 to $20.00 and set a "buy" rating on the stock in a research note on Wednesday...
MarketBeat·29d ago
News Placeholder
Beta Bionics Q1 Earnings Call Highlights
Beta Bionics (NASDAQ:BBNX) reported first-quarter 2026 net sales of $27.6 million, up 57% year-over-year, as management cited growth in new patient starts, a rising base of recurring pharmacy users, and continued expansion of pharmacy channel access for its iLet insulin delivery system. Quarterly r...
MarketBeat·30d ago
News Placeholder
Beta Bionics BBNX Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·30d ago
News Placeholder
Beta Bionics Q1 2026 Earnings Call Transcript
read more...
Benzinga·30d ago
News Placeholder
Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates
Beta Bionics, Inc. (BBNX) delivered earnings and revenue surprises of +8.24% and -0.45%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·30d ago
News Placeholder
Beta Bionics (NASDAQ:BBNX) Trading Down 4.9% Following Analyst Downgrade
Beta Bionics (NASDAQ:BBNX) Shares Down 4.9% After Analyst Downgrade...
MarketBeat·1mo ago
News Placeholder
Beta Bionics, Inc. (BBNX) Soars 10.3%: Is Further Upside Left in the Stock?
Beta Bionics, Inc. (BBNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·1mo ago
<
1
2
...
>

Latest BBNX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.